WindRose Health Investors LLC, a New York-based healthcare private equity firm, has purchased SubjectWell, a patient access marketplace that connects people with health conditions to care options.
SubjectWell’s marketplace of patients with health conditions is growing by over 300,000 patients per month, according to the company. This marketplace, built on SubjectWell’s patient recruitment technology, allows SubjectWell to support global vaccine, chronic, rare disease and oncology clinical studies for pharma, biotech, clinical research sites, clinical research organizations and other healthcare clients.
McDermott Will & Emery LLP acted as legal advisor to WindRose and Silicon Legal Strategy acted as legal advisor to SubjectWell.